Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

In Vivo Pharmacodynamic Evaluation of Kasumi Cell Line Based Leukemia/Lymphoma (CAT#: STEM-AE-0060-LGZ)

Introduction

Leukemia usually refers to a state of malignant blood tumor cells in bone marrow and peripheral blood. The usual standard is that malignant tumor cells in bone marrow or peripheral blood exceed 20%, which is called leukemia. These malignant blood tumor cells are called lymphocytic leukemia if they are lymphocytes; If the malignant hematologic tumor cells are granulocytes, it is myelogenous leukemia; If the malignant blood tumor cells are NK cells, it is NK cell leukemia. According to the course of disease and degree of differentiation, can also be divided into acute or chronic.<br />Lymphoma is a malignant tumor of lymphocyte, usually in the form of lumps, commonly known as lymphoma; But it can actually start in the form of leukemia, lymphocytic leukemia. So lymphoma broadly includes lymphocytic leukemia.




Principle

In vivo activity is the gold standard for the evaluation of drug biological activity, and it is the first verification of non-human comprehensive activity. In vivo pharmacodynamic evaluation plays a decisive role in the confirmation of candidate molecules and the screening of clinical target indications, and is an indispensable link in the development of new drugs. We provide a variety of disease animal models including inflammation, immunity, metabolism, etc., to meet the needs of different new drug research and development projects of customers, and accept customized services.
In vivo pharmacodynamic evaluation, as the basic research of new drugs, is carried out on animals. It is to verify the effect of drugs with the comprehensive participation of a number of other factors, and to understand the effect of drugs on a certain part of the body by comparing and analyzing the animal signs, in vitro organs, blood components, histone expression and tissue changes before and after drug administration.

Applications

Leukemia/Lymphoma

Procedure

1. Disease model construction.
2. Mice dosing.
3. Efficacy monitoring.
4. Biochemical detection of tissue samples.

Materials

• Sample Type: liquid or powder

Notes

Oncology efficacy Service package:
In vivo syngeneic model
In vivo CDX model
In vivo PBMC humanized model
In vivo transgenic mouse model
In vivo orthotropic or Metastasis tumor model
Advertisement